E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities

被引：0
作者：
Qiang Zou
Meng Liu
Kewei Liu
Yi Zhang
Brian J. North
Bin Wang
机构：
[1] Chongqing University Cancer Hospital,Department of Hepatobiliary Pancreatic Tumor Center
[2] Chongqing University Medical School,Department of Gastroenterology & Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital
[3] Army Medical University (Third Military Medical University),Department of Gastroenterology, Chongqing University Cancer Hospital
[4] Chongqing University Medical School,Biomedical Sciences Department
[5] Creighton University School of Medicine,Institute of Pathology and Southwest Cancer Center, and Key Laboratory of Tumor Immunopathology of Ministry of Education of China, Southwest Hospital
[6] Army Medical University (Third Military Medical University),undefined
[7] Jinfeng Laboratory,undefined
来源：
Cellular Oncology | 2023年 / 46卷
关键词：
Cancer stem cells (CSCs); Ubiquitin-proteosome system; E3 ubiquitin ligases; Proteolysis-targeting chimera (PROTAC); Molecularly targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：545 / 570
页数：25
相关论文
共 1321 条
[1]  
Batlle E(2017)Cancer stem cells revisited Nat. Med. 23 1124-1134
[2]  
Clevers H(2022)Hallmarks of Cancer: New dimensions Cancer Discov. 12 31-46
[3]  
Hanahan D(2015)Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5(+) liver cancer initiating cells by suppressing negative regulators of β-catenin signaling Oncogene 34 3188-3198
[4]  
Lei ZJ(2015)Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2 Oncogene 34 1407-1419
[5]  
Wang J(2020)The role of ubiquitination in tumorigenesis and targeted drug discovery Signal 5 11-229
[6]  
Xiao HL(2012)The ubiquitin code Annu. Rev. Biochem. 81 203-192
[7]  
Guo Y(2017)Mechanisms of Deubiquitinase specificity and regulation Annu. Rev. Biochem. 86 159-24
[8]  
Wang T(2018)SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance Cancer Lett. 430 11-2100
[9]  
Li Q(2018)Epigenetic restriction of hippo signaling by MORC2 underlies stemness of hepatocellular carcinoma cells Cell Death Differ. 25 2086-232
[10]  
Liu L(2020)Targeting cancer stem cell pathways for cancer therapy Sig. Transduct. Target. Ther. 5 8-369
12345678910